Jenna Forsythe Discusses Updates in Leukemia Treatment
Jenna Forsythe, MSN, RN, OCN, a nurse in the leukemia and lymphoma outpatient center at John Theurer Cancer Center, discusses updates in leukemia treatment and the effect it has had in practice.
Jenna Forsythe, MSN, RN, OCN, a nurse in the leukemia and lymphoma outpatient center at John Theurer Cancer Center, discusses updates in leukemia treatment and the effect it has had in practice.
Forsythe says new biotherapies, which are targeting the “bad cells†in the patient, are becoming more common. Because the therapy is more direct, patients are seeing fewer side effects. Because the patients are less sick, nurses can do more to treat them, Forsythe says. ​
Acalabrutinib Plus Chemoimmunotherapy Improves PFS in Mantle Cell Lymphoma
May 6th 2024Patients with untreated mantle cell lymphoma treated with acalabrutinib plus bendamustine and rituximab had significant improvements in progression-free survival compared with bendamustine and rituximab alone.
